<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The expression of microRNA-21 (miR-21) was determined in 42 patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) using real-time reverse transcription-polymerase chain reaction </plain></SENT>
<SENT sid="1" pm="."><plain>The level of miR-21 in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> tissue was compared with paired <z:mpath ids='MPATH_458'>normal</z:mpath> adjacent tissue (NAT) and the relationships of miR-21 levels to clinicopathological characteristics and pathological <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> response to neoadjuvant chemotherapy were investigated </plain></SENT>
<SENT sid="2" pm="."><plain>There was a significantly higher level of miR-21 in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> tissue than in NAT and high expression of miR-21 was significantly correlated with advanced clinical stage and poor cell differentiation </plain></SENT>
<SENT sid="3" pm="."><plain>Receiver operating characteristic curve analysis indicated a maximum optimal cut-off cycle threshold value of 10.32 for differentiating pathological responders from non-responders, with a sensitivity of 80.0% and specificity of 88.2% </plain></SENT>
<SENT sid="4" pm="."><plain>These data showed that miR-21 was significantly overexpressed in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> tissue and was associated with advanced <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, and that miR-21 may be a potential candidate biomarker for predicting pathological <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> response to chemotherapy </plain></SENT>
</text></document>